Orexo receives million 5£ milestone payment for Abstral® in Europe and Zubsolv® continues strong market share growth in the US
Dec 17, 2014
OTC Disclosure News Service
Stockholm, Uppsala, Sweden
This release includes additional documents. Select the link(s) below to view.
Copyright © 2014 OTC Markets. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.